Paper30980353
Anionic Lipid Clustering Model.
Epand RM. Adv Exp Med Biol, 2019. Cited by 19 papers, by iCite.
Cite this record
ConductScience Library. Anionic Lipid Clustering Model. Papers, record 30980353. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30980353
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antimicrobial Cationic Peptides | Major topic |
| Bacteria | Major topic |
| Cell Membrane | Major topic |
| Lipids | Major topic |
| Lipid Bilayers |
Source PubMed
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40005137 | Antibiofilm Activities of Tritrpticin Analogs Against Pathogenic Pseudomonas aeruginosa PA01 Strains. | Molecules | 2025 | https://conductscience.org/library/papers/40005137 | PubMed |
| 39769953 | Proline-Rich Antimicrobial Peptides from Invertebrates. | Molecules | 2024 | https://conductscience.org/library/papers/39769953 | PubMed |
| 39389804 | Emerging roles of antimicrobial peptides in innate immunity, neuronal function, and neurodegeneration. | Trends Neurosci | 2024 | https://conductscience.org/library/papers/39389804 | PubMed |
| 38319435 | Antimicrobial and antitumor properties of anuran peptide temporin-SHf induce apoptosis in A549 lung cancer cells. | Amino Acids | 2024 | https://conductscience.org/library/papers/38319435 | PubMed |
| 37547452 | The effect of metalation on antimicrobial piscidins imbedded in normal and oxidized lipid bilayers. | RSC Chem Biol | 2023 | https://conductscience.org/library/papers/37547452 | PubMed |
| 36485036 | Peptide Stability Is Important but Not a General Requirement for Antimicrobial and Antibiofilm Activity In Vitro and In Vivo. | Mol Pharm | 2023 | https://conductscience.org/library/papers/36485036 | PubMed |
| 36422158 | Discovery of the Potentiator of the Pore-Forming Ability of Lantibiotic Nisin: Perspectives for Anticancer Therapy. | Membranes (Basel) | 2022 | https://conductscience.org/library/papers/36422158 | PubMed |
| 36361660 | Expanding the Landscape of Amino Acid-Rich Antimicrobial Peptides: Definition, Deployment in Nature, Implications for Peptide Design and Therapeutic Potential. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36361660 | PubMed |
| 35731709 | Essential Role of Enzymatic Activity in the Leishmanicidal Mechanism of the Eosinophil Cationic Protein (RNase 3). | ACS Infect Dis | 2022 | https://conductscience.org/library/papers/35731709 | PubMed |
| 35047897 | Deuterium Solid State NMR Studies of Intact Bacteria Treated With Antimicrobial Peptides. | Front Med Technol | 2020 | https://conductscience.org/library/papers/35047897 | PubMed |
| 34529321 | The evolution of the antimicrobial peptide database over 18 years: Milestones and new features. | Protein Sci | 2022 | https://conductscience.org/library/papers/34529321 | PubMed |
| 32784626 | Bioinformatic Analysis of 1000 Amphibian Antimicrobial Peptides Uncovers Multiple Length-Dependent Correlations for Peptide Design and Prediction. | Antibiotics (Basel) | 2020 | https://conductscience.org/library/papers/32784626 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30980353
GET https://conductscience.org/api/papers/v1/30980353/authors